Leflunomide and Warfarin Interaction Management

Monitoring and Dose Adjustment

• The American College of Cardiology recommends increasing INR monitoring frequency immediately upon initiating leflunomide in warfarin-treated patients, with monitoring at baseline, then weekly for the first month, then every 2 weeks for the second month, then monthly if stable, to minimize the risk of bleeding due to increased INR, with a strength of evidence based on clinical guidelines 1
• Consider prophylactic warfarin dose reduction of 20-30% when initiating leflunomide, though this must be guided by INR response, as recommended by clinical guidelines to prevent excessive anticoagulation 1

Alternative Anticoagulation Options

• The American Heart Association suggests considering alternative anticoagulation, such as low molecular weight heparin (LMWH), which avoids drug-drug interactions with leflunomide and may be preferable in patients with multiple risk factors for bleeding, based on evidence from clinical studies 1
• Direct oral anticoagulants (DOACs) have fewer drug interactions than warfarin, though specific leflunomide interaction data is limited, according to research published in Circulation: Arrhythmia and Electrophysiology 2